Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marom, E. M.
Right arrow Articles by Patz, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marom, E. M.
Right arrow Articles by Patz, E. F., Jr
(Radiology. 1999;212:803-809.)
© RSNA, 1999

Nuclear Medicine

Staging Non-Small Cell Lung Cancer with Whole-Body PET1

Edith M. Marom, MD, H. Page McAdams, MD, Jeremy J. Erasmus, MD, Philip C. Goodman, MD, Donna K. Culhane, MD, R. Edward Coleman, MD, James E. Herndon, MD and Edward F. Patz, Jr, MD

1 From the Departments of Radiology (E.M.M., H.P.M., J.J.E., P.C.G., R.E.C., E.F.P.) and Medicine (J.E.H.), Duke University Medical Center, Box 3808, Durham, NC 27710; and the Department of Radiology, Veterans Affairs Medical Center, Durham, NC (D.K.C.). Received July 27, 1998; revision requested September 24; final revision received December 9; accepted March 29, 1999. Address reprint requests to E.F.P.

PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic computed tomography [CT], bone scintigraphy, and brain CT or magnetic resonance [MR] imaging) in staging bronchogenic carcinoma.

MATERIALS AND METHODS: Within 20 months, 100 patients with newly diagnosed bronchogenic carcinoma underwent whole-body FDG PET and chest CT. Ninety of these patients underwent radionuclide bone scintigraphy, and 70 patients underwent brain CT or MR imaging. For each patient, all examinations were completed within 1 month. A radiologic stage was assigned by using PET and conventional imaging independently and was compared with the pathologic stage. The accuracy, sensitivity, specificity, and negative and positive predictive values were calculated.

RESULTS: PET staging was accurate in 83 (83%) patients; conventional imaging staging was accurate in 65 (65%) patients (P < .005). Staging with mediastinal lymph nodes was correct by using PET in 67 (85%) patients and by using CT in 46 (58%) patients (P < .001). Nine (9%) patients had metastases demonstrated by using PET that were not found with conventional imaging, whereas 10 (10%) patients suspected of having metastases because of conventional imaging findings were correctly shown with PET to not have metastases.

CONCLUSION: Whole-body PET was more accurate than thoracic CT, bone scintigraphy, and brain CT or MR imaging in staging bronchogenic carcinoma.

Index terms: Bronchi, neoplasms, 60.3211, 60.3212, 60.3214, 60.3216, 60.3217 • Lung neoplasms, emission CT (ECT), 60.12163 • Lung neoplasms, staging, 60.3211, 60.3212, 60.3214, 60.3216, 60.3217




This article has been cited by other articles:


Home page
 RadiologyHome page
C. A Yi, K. M. Shin, K. S. Lee, B.-T. Kim, H. Kim, O J. Kwon, J. Y. Choi, and M. J. Chung
Non-Small Cell Lung Cancer Staging: Efficacy Comparison of Integrated PET/CT versus 3.0-T Whole-Body MR Imaging
Radiology, August 1, 2008; 248(2): 632 - 642.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. K. Hoang, L. F. Hoagland, R. E. Coleman, A. D. Coan, J. E. Herndon II, and E. F. Patz Jr
Prognostic Value of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Imaging in Patients With Advanced-Stage Non-Small-Cell Lung Carcinoma
J. Clin. Oncol., March 20, 2008; 26(9): 1459 - 1464.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Y. C. Ung, D. E. Maziak, J. A. Vanderveen, C. A. Smith, K. Gulenchyn, C. Lacchetti, W. K. Evans, and Lung Cancer Disease Site Group of Cancer Care Onta
18Fluorodeoxyglucose Positron Emission Tomography in the Diagnosis and Staging of Lung Cancer: A Systematic Review
J Natl Cancer Inst, December 5, 2007; 99(23): 1753 - 1767.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. Hellwig, T. P. Graeter, D. Ukena, A. Groeschel, G. W. Sybrecht, H.-J. Schaefers, and C.-M. Kirsch
18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?
J. Nucl. Med., November 1, 2007; 48(11): 1761 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. A. Silvestri, M. K. Gould, M. L. Margolis, L. T. Tanoue, D. McCrory, E. Toloza, and F. Detterbeck
Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 178S - 201S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Singh, B. Camazine, Y. Jadhav, R. Gupta, P. Mukhopadhyay, A. Khan, R. Reddy, Q. Zheng, D. D. Smith, R. Khode, et al.
Endoscopic Ultrasound As a First Test for Diagnosis and Staging of Lung Cancer: A Prospective Study
Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 345 - 354.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
K. E. Posther, L. M. McCall, D. H. Harpole Jr., C. E. Reed, J. B. Putnam Jr., V. W. Rusch, and B. A. Siegel
Yield of Brain 18F-FDG PET in Evaluating Patients with Potentially Operable Non-Small Cell Lung Cancer
J. Nucl. Med., October 1, 2006; 47(10): 1607 - 1611.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
T. C. McLoud
"A system for the clinical staging of lung cancer"--a commentary.
Am. J. Roentgenol., August 1, 2006; 187(2): 269 - 270.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
S. Shiraishi, S. Tomiguchi, D. Utsunomiya, K. Kawanaka, K. Awai, S. Morishita, T. Okuda, K. Yokotsuka, and Y. Yamashita
Quantitative Analysis and Effect of Attenuation Correction on Lymph Node Staging of Non-Small Cell Lung Cancer on SPECT and CT.
Am. J. Roentgenol., May 1, 2006; 186(5): 1450 - 1457.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Hishida, K. Nagai, J. Yoshida, M. Nishimura, G.-i. Ishii, M. Iwasaki, and Y. Nishiwaki
Is surgical resection indicated for a solitary non-small cell lung cancer recurrence?
J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 838 - 842.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. Prevost, L. Boucher, P. Larivee, R. Boileau, and F. Benard
Bone Marrow Hypermetabolism on 18F-FDG PET as a Survival Prognostic Factor in Non-Small Cell Lung Cancer
J. Nucl. Med., April 1, 2006; 47(4): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
T. Bunyaviroch and R. E. Coleman
PET Evaluation of Lung Cancer
J. Nucl. Med., March 1, 2006; 47(3): 451 - 469.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. Birim, A. P. Kappetein, and A. J.J.C. Bogers
Reply
Ann. Thorac. Surg., November 1, 2005; 80(5): 1980 - 1981.
[Full Text] [PDF]

Home page
 JCOHome page
D. B. Costa, J. A. Parker, and S. T. Schumer
Modern Treatment of Lung Cancer: CASE 3. Non-Metastatic Bilateral F-18 Fluorodeoxyglucose Avid Adrenal Glands in Non-Small-Cell Lung Cancer
J. Clin. Oncol., October 20, 2005; 23(30): 7740 - 7742.
[Full Text] [PDF]

Home page
 JCOHome page
D. Lardinois, W. Weder, M. Roudas, G. K. von Schulthess, M. Tutic, H. Moch, R. A. Stahel, and H. C. Steinert
Etiology of Solitary Extrapulmonary Positron Emission Tomography and Computed Tomography Findings in Patients With Lung Cancer
J. Clin. Oncol., October 1, 2005; 23(28): 6846 - 6853.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Onn, D. H. Choe, R. S. Herbst, A. M. Correa, R. F. Munden, M. T. Truong, A. A. Vaporciyan, T. Isobe, M. Z. Gilcrease, and E. M. Marom
Tumor Cavitation in Stage I Non-Small Cell Lung Cancer: Epidermal Growth Factor Receptor Expression and Prediction of Poor Outcome
Radiology, October 1, 2005; 237(1): 342 - 347.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
S. S. Shim, K. S. Lee, B.-T. Kim, M. J. Chung, E. J. Lee, J. Han, J. Y. Choi, O J. Kwon, Y. M. Shim, and S. Kim
Non-Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging
Radiology, September 1, 2005; 236(3): 1011 - 1019.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. K. Shankar and D. C. Sullivan
Functional Imaging in Lung Cancer
J. Clin. Oncol., May 10, 2005; 23(14): 3203 - 3211.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al.
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. Birim, A. P. Kappetein, T. Stijnen, and A. J.J.C. Bogers
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer
Ann. Thorac. Surg., January 1, 2005; 79(1): 375 - 382.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
G. Antoch, N. Saoudi, H. Kuehl, G. Dahmen, S. P. Mueller, T. Beyer, A. Bockisch, J. F. Debatin, and L. S. Freudenberg
Accuracy of Whole-Body Dual-Modality Fluorine-18-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PET
J. Clin. Oncol., November 1, 2004; 22(21): 4357 - 4368.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Oncologist, November 1, 2004; 9(6): 633 - 643.
[Abstract] [Full Text] [PDF]

Home page
 ImagingHome page
L N Gomersall and S Olson
Imaging in lung cancer
Imaging, October 1, 2004; 16(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. L. Aquino and A. J. Fischman
Does Whole-Body 2-[18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Have an Advantage Over Thoracic Positron Emission Tomography for Staging Patients With Lung Cancer?
Chest, September 1, 2004; 126(3): 755 - 760.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
F. C. Detterbeck, S. Falen, M. P. Rivera, J. S. Halle, and M. A. Socinski
Seeking a Home for a PET, Part 2: Defining the Appropriate Place for Positron Emission Tomography Imaging in the Staging of Patients With Suspected Lung Cancer
Chest, June 1, 2004; 125(6): 2300 - 2308.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Rohren, T. G. Turkington, and R. E. Coleman
Clinical Applications of PET in Oncology
Radiology, May 1, 2004; 231(2): 305 - 332.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Kahn, Y. Menda, K. Kernstine, D. Bushnell, K. McLaughlin, S. Miller, and K. Berbaum
The Utility of 99mTc Depreotide Compared With F-18 Fluorodeoxyglucose Positron Emission Tomography and Surgical Staging in Patients With Suspected Non-small Cell Lung Cancer
Chest, February 1, 2004; 125(2): 494 - 501.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
E. Even-Sapir, U. Metser, G. Flusser, L. Zuriel, Y. Kollender, H. Lerman, G. Lievshitz, I. Ron, and E. Mishani
Assessment of Malignant Skeletal Disease: Initial Experience with 18F-Fluoride PET/CT and Comparison Between 18F-Fluoride PET and 18F-Fluoride PET/CT
J. Nucl. Med., February 1, 2004; 45(2): 272 - 278.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
U. Metser, H. Lerman, A. Blank, G. Lievshitz, F. Bokstein, and E. Even-Sapir
Malignant Involvement of the Spine: Assessment by 18F-FDG PET/CT
J. Nucl. Med., February 1, 2004; 45(2): 279 - 284.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. G. Pfister, D. H. Johnson, C. G. Azzoli, W. Sause, T. J. Smith, S. Baker Jr, J. Olak, D. Stover, J. R. Strawn, A. T. Turrisi, et al.
American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003
J. Clin. Oncol., January 15, 2004; 22(2): 330 - 353.
[Full Text] [PDF]

Home page
 JNMHome page
G. W. Goerres, G. K. von Schulthess, and H. C. Steinert
Why Most PET of Lung and Head-and-Neck Cancer Will Be PET/CT
J. Nucl. Med., January 1, 2004; 45(90010): 66S - 71.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
M. K. Gould, W. G. Kuschner, C. E. Rydzak, C. C. Maclean, A. N. Demas, H. Shigemitsu, J. K. Chan, and D. K. Owens
Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non-Small-Cell Lung Cancer: A Meta-Analysis
Ann Intern Med, December 2, 2003; 139(11): 879 - 892.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
C. E. Reed, D. H. Harpole, K. E. Posther, S. L. Woolson, R. J. Downey, B. F. Meyers, R. T. Heelan, H. A. MacApinlac, S.-H. Jung, G. A. Silvestri, et al.
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1943 - 1951.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
G. Antoch, J. Stattaus, A. T. Nemat, S. Marnitz, T. Beyer, H. Kuehl, A. Bockisch, J. F. Debatin, and L. S. Freudenberg
Non-Small Cell Lung Cancer: Dual-Modality PET/CT in Preoperative Staging
Radiology, November 1, 2003; 229(2): 526 - 533.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
A. K. Buck, G. Halter, H. Schirrmeister, J. Kotzerke, I. Wurziger, G. Glatting, T. Mattfeldt, B. Neumaier, S. N. Reske, and M. Hetzel
Imaging Proliferation in Lung Tumors with PET: 18F-FLT Versus 18F-FDG
J. Nucl. Med., September 1, 2003; 44(9): 1426 - 1431.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. Lardinois, W. Weder, T. F. Hany, E. M. Kamel, S. Korom, B. Seifert, G. K. von Schulthess, and H. C. Steinert
Staging of Non-Small-Cell Lung Cancer with Integrated Positron-Emission Tomography and Computed Tomography
N. Engl. J. Med., June 19, 2003; 348(25): 2500 - 2507.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
E. V. Dizendorf, B. G. Baumert, G. K. von Schulthess, U. M. Lutolf, and H. C. Steinert
Impact of Whole-Body 18F-FDG PET on Staging and Managing Patients for Radiation Therapy
J. Nucl. Med., January 1, 2003; 44(1): 24 - 29.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
E. M. Toloza, L. Harpole, and D. C. McCrory
Noninvasive Staging of Non-small Cell Lung Cancer: A Review of the Current Evidence
Chest, January 1, 2003; 123(1_suppl): 137S - 146S.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Rohren, J. M. Provenzale, D. P. Barboriak, and R. E. Coleman
Screening for Cerebral Metastases with FDG PET in Patients Undergoing Whole-Body Staging of Non-Central Nervous System Malignancy
Radiology, January 1, 2003; 226(1): 181 - 187.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. G. Spiro and J. C. Porter
Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
N. R. Dunnick and M. Korobkin
Imaging of Adrenal Incidentalomas: Current Status
Am. J. Roentgenol., September 1, 2002; 179(3): 559 - 568.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
N. Hollings and P. Shaw
Diagnostic imaging of lung cancer
Eur. Respir. J., April 1, 2002; 19(4): 722 - 742.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A G Pitman, R J Hicks, D S Binns, R E Ware, V Kalff, A F McKenzie, D L Ball, and M P MacManus
Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses
Br. J. Radiol., February 1, 2002; 75(890): 114 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste
Imaging in lung cancer: positron emission tomography scan
Eur. Respir. J., February 1, 2002; 19(35_suppl): 49S - 60s.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Laking and P Price
18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer
Thorax, September 1, 2001; 56(90002): ii38 - 44.
[Full Text] [PDF]

Home page
 JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
V. Kalff, R. J. Hicks, M. P. MacManus, D. S. Binns, A. F. McKenzie, R. E. Ware, A. Hogg, and D. L. Ball
Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non-Small-Cell Lung Cancer: A Prospective Study
J. Clin. Oncol., January 1, 2001; 19(1): 111 - 118.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. A. Podoloff and E. M. Marom
Non-Small Cell Lung Cancer: Staging at Whole-Body PET Dr Marom responds:
Radiology, December 1, 2000; 217(3): 918 - 919.
[Full Text]

Home page
 RadioGraphicsHome page
E. F. Patz Jr
1999 Plenary Session: Friday Imaging Symposium : Evaluation of Focal Pulmonary Abnormalities with FDG PET
RadioGraphics, July 1, 2000; 20(4): 1182 - 1185.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1999 by the Radiological Society of North America.